Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501266 | SCV000595379 | likely benign | not specified | 2016-08-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001078592 | SCV000638627 | likely benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316438 | SCV000850464 | likely benign | Inborn genetic diseases | 2017-01-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000557391 | SCV001144378 | benign | not provided | 2019-08-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000557391 | SCV001768518 | likely benign | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848869 | SCV002105262 | likely benign | Hereditary spastic paraplegia | 2019-11-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000557391 | SCV004042129 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | KIF1A: BP4, BP7 |
Prevention |
RCV004535599 | SCV004743978 | likely benign | KIF1A-related disorder | 2019-09-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |